The Vascular Endothelial Growth Factor (VEGF)/VEGF receptor (VEGFR) axis is the most prominent pathway both in physiological and tumour-induced neoangiogenesis and is a therapeutic target in different types of cancers [30,31,32]. Here, VEGFA is linked to neoplasm.